Atlas Trials

Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Clinical trial NCT04970498 · UNKNOWN

Trial details

NCT number
NCT04970498
Sponsor
Peking University Third Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Rectal Cancer Stage IIRectal Cancer Stage III
Start date
2021-02-01
Primary completion
2022-08-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.